NCT00533195 Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT00515047 Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis Status COMPLETED Phase N/A
NCT00510003 Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old Status COMPLETED Phase PHASE4
NCT00509990 Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting Status COMPLETED Phase PHASE4
NCT00509535 Prospective, Randomized, Double Blind Comparative Study on the Use of Two Creams in Xerosis Atopic Probands Status COMPLETED Phase NA
NCT00475605 A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis Status TERMINATED Phase N/A
NCT00460083 Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT00455429 An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT00438022 Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis Status COMPLETED Phase N/A
NCT00407979 Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis Status COMPLETED Phase N/A
NCT00407069 Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus Status COMPLETED Phase N/A
NCT00406081 Immune Response to Varicella Vaccination in Children With Atopic Dermatitis Status COMPLETED Phase N/A
NCT00389103 Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD) Status WITHDRAWN Phase PHASE1
NCT00379678 Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis Status COMPLETED Phase N/A
NCT00376129 Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE2